Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FOKUS JØRPELAND AS
AS
Active
Org 929385047
Gråsteinveien 19, 4027 Stavanger
Traditional, complementary and alternative medicine activities · NACE 8696
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,6M
+13% vs 2023
EBITDA margin
5.1%
+174% vs 2023
Equity ratio
-16.3%
Financial strength
Net profit 2024
NOK 125K
+167% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 2,6M
+13%
EBITDA
NOK 132K
+174%
Net profit
NOK 125K
+167%
Total assets
NOK 298K
-31%
Equity
NOK -49K
+72%
Employees
1
—
Company information
Legal name
FOKUS JØRPELAND AS
Org number
929385047
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
22. juni 2022
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Naprapat- og manuell behandling, samt deltakelse i annen virksomhet.
Contact
Address
Gråsteinveien 19, 4027 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Traditional, complementary and alternative medicine activities
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
0M
2022
2M
2023
3M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
2 261
2 560
Staff expenses
−0
−868
−674
EBITDA
−14
−178
132
Depreciation & amort.
−4
−8
−8
EBIT
−18
−186
124
Net financials
0
0
1
Profit before tax
−18
−186
125
Tax
−0
−0
−0
Net profit
−18
−186
125
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
51
434
298
Equity
12
−173
−49
Long-term debt
0
0
0
Short-term debt
39
610
347
Total debt
39
610
347
Financial ratios
5-year trend
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
2022
2024
Equity ratio
-16.3%
This company
38.2%
Market median
-143% vs market
2022
2024
Return on equity
12471000.0%
This company
18.4%
Market median
+67777074% vs market
2022
2024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
2022
2024
Asset turnover
8.58×
This company
1.12×
Market median
+666% vs market
2022
2024
Debt / equity
7.14×
This company
0.62×
Market median
-1052% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-06-21 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LA
Lise Andersen
Chairman
2022
RF
Rune Fagermoen
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Puravida Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Puravida Holding As
FOKUS JØRPELAND AS
(this company)
Board network connections
Board members of FOKUS JØRPELAND AS also hold positions in
0
other companies.
Person
Role here
Other companies
Lise Andersen
Chairman
0 companies
Rune Fagermoen
Board of Directors
0 companies